Skip to main content
Krka logo

Krka — Investor Relations & Filings

Ticker · KRKG ISIN · SI0031102120 LEI · 549300H9RLRTRTLRUZ73 LJSE Manufacturing
Open in API
Filings indexed 1,887 across all filing types
Latest filing 2024-01-29 Transaction in Own Shar…
Country SI Slovenia
Listing LJSE KRKG

About Krka

https://www.krka.biz/en/

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Recent filings

Filing Released Lang Actions
Detailed report on acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document explicitly details 'acquisition of treasury shares' over a specific period (19 January to 25 January 2024), listing the volume and price of executed transactions. This activity falls directly under the definition of a company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category.
2024-01-29 English
Acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its category as 'Acquisition or disposal of the issuer's own shares' and details the 'Acquisition of treasury shares' over a specific period (January 19 to January 25, 2024). This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The filing code POS matches this activity.
2024-01-29 English
Podrobno poročilo o nakupih lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document title, translated from Slovenian, is "Detailed report on the purchase of own shares in the period from 19. 1. 2024 to 25. 1. 2024". The content consists of a detailed table listing dates, times, quantities, and prices of share transactions. This explicitly details the company's activity in buying back its own stock. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase reports.
2024-01-29 English
Pridobivanje lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document text is titled 'Pridobivanje lastnih delnic' (Acquisition of own shares) and details the number of shares repurchased by the company (Krka, d. d.) between January 19, 2024, and January 25, 2024. This directly corresponds to the definition of a company buying back or selling its own shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate classification. The document length is short (1776 chars) and it reports specific transaction details, not just announcing a report.
2024-01-29 Slovene
Detailed report on acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document explicitly details 'acquisition of treasury shares' over a specific period (19 January to 25 January 2024), listing the volume and price of executed transactions. This activity falls directly under the definition of a company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category.
2024-01-26 English
Notification on establishment of a joint venture in India
M&A Activity Classification · 99% confidence The document is explicitly titled "PRESS RELEASE" and announces a significant corporate action: the establishment of a joint venture between Krka and Laurus Labs Ltd. This type of announcement, detailing strategic business developments, capital commitments (up to 50 million euros), and management commentary, does not fit the specific definitions for financial reports (10-K, IR, ER), regulatory filings (RNS), or shareholder actions (AGM-R, DVA). It is a material corporate event announcement. Since there is no specific category for 'Joint Venture Announcement' or 'Strategic Partnership,' the most appropriate general category for significant, non-standard corporate news that is not a standard financial report or insider transaction is 'Regulatory Filings' (RNS), as it serves as a general announcement mechanism for material, non-prescribed information, or potentially 'Capital/Financing Update' (CAP) due to the registered capital involved. However, given the nature is a strategic business combination announcement, RNS is the best fit among the provided options for a general press release about a major business development not covered elsewhere. It is not a report itself, so RPA is incorrect. It is not about management changes (MANG) or director trades (DIRS). Therefore, RNS is the fallback for this material press release.
2024-01-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.